Oregon Medical Research Center   Report issue

For profit Phase 2 Phase 3
Founded: Portland OR United States (1998)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Oregon Medical Research | Oregon Medical Research Center | Oregon Medical Research Center, PC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Keratosis, Seborrheic (Phase 2)

Onychomycosis (Phase 2)

Psoriasis (Phase 2)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 8